22157.jpg
Tyrokinse Kinase Inhibitors in the Global Oncology Market 2021: Market Leaders by Indication and Product
05 nov. 2021 05h58 HE | Research and Markets
Dublin, Nov. 05, 2021 (GLOBE NEWSWIRE) -- The "Oncology Markets for Tyrokinse Kinase Inhibitors" report has been added to ResearchAndMarkets.com's offering. Traditional cancer therapy has focused...
22157.jpg
Global High Throughput Screening (HTS) Markets 2021-2027: Resolving Technical Limitations - The Cornerstone for Future Success of Cell-based HTS
19 août 2021 05h58 HE | Research and Markets
Dublin, Aug. 19, 2021 (GLOBE NEWSWIRE) -- The "High Throughput Screening (HTS) - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global High...
22157.jpg
Anaplastic Lymphoma Kinase ALK Inhibitors Market, 2026
10 août 2021 04h48 HE | Research and Markets
Dublin, Aug. 10, 2021 (GLOBE NEWSWIRE) -- The "Global Anaplastic Lymphoma Kinase ALK Inhibitors Market, Drug Sales, Price & Clinical Trials Insight 2026" report has been added to...
22157.jpg
Global Kinase Inhibitors Market Report 2021-2026Featuring Major Players - Pfizer, Novartis, AstraZeneca, Bayer, Eisai and Johnson & Johnson
02 juil. 2021 08h08 HE | Research and Markets
Dublin, July 02, 2021 (GLOBE NEWSWIRE) -- The "Global Kinase Inhibitors Market 2021-2026" report has been added to ResearchAndMarkets.com's offering. The global market for kinase inhibitors should...
22157.jpg
Insights on the Anaplastic Lymphoma Kinase ALK Inhibitors Global Market to 2026 - Lorbrena Overcomes Xalkori as Front-Line Therapy in NSCLC
21 avr. 2021 04h58 HE | Research and Markets
Dublin, April 21, 2021 (GLOBE NEWSWIRE) -- The "Global Anaplastic Lymphoma Kinase ALK Inhibitors Market, Drug Sales, Price & Clinical Trials Insight 2026" report has been added to...
22157.jpg
$1.7 Billion Recombinant Proteins Markets, 2021-2026 - Increasing Focus on Biomarker Discovery
05 mars 2021 05h43 HE | Research and Markets
Dublin, March 05, 2021 (GLOBE NEWSWIRE) -- The "Global Recombinant Proteins Market by Product (Growth Factors, Chemokines, Structural Proteins, Membrane Proteins), Application (Drug Discovery &...
22157.jpg
Worldwide Glycobiology Industry to 2025 - Impact Analysis of COVID-19
11 nov. 2020 06h23 HE | Research and Markets
Dublin, Nov. 11, 2020 (GLOBE NEWSWIRE) -- The "Global Glycobiology Market By Type of Enzyme (Glycosidases & Neuramidases, Glycosyltransferases & Sialytransferases, Carbohydrate kinases,...
22157.jpg
Global Kinase Inhibitors Markets 2019-2020 & 2027 - Surge in Product Approvals & Increase in Incident of Cancer Diseases
09 sept. 2020 06h58 HE | Research and Markets
Dublin, Sept. 09, 2020 (GLOBE NEWSWIRE) -- The "Kinase Inhibitors - Global Market Outlook (2019-2027)" report has been added to ResearchAndMarkets.com's offering. The Global Kinase Inhibitors...
MolecularMD Corp. Obtains Exclusive License to LKB1 Uses in Non-Small Cell Lung Cancer
28 janv. 2013 08h30 HE | MolecularMD
PORTLAND, OR--(Marketwire - Jan 28, 2013) - MolecularMD Corp. announced today that it has entered into a license agreement granting the company exclusive patent rights to cancer diagnosis...